BioSpace News Archive

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced with HUTCHMED that the results of the Phase 1b study in advanced colorectal cancer patients were released in an poster discussion at the 2021 American Association for Clinical Oncology Annual Meeting.

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced that the results of the Phase Ia/Ib study of IBI110 were released in a poster presentation at the American Society of Clinical Oncology Annual Meeting 2021.

Ascletis Pharma Inc. announces that China National Medical Products Administration has approved the Investigational New Drug application for its drug candidate ASC42 to conduct clinical trials for chronic hepatitis B indication.